The Stub1 Knockout RCS Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the rat chondrosarcoma line RCS, designed to eliminate functional expression of the Stub1 gene (encoding STUB1, also known as CHIP). This loss-of-function model enables investigation of STUB1-dependent protein quality control mechanisms. The knockout cell line provides a stable genetic background for studying the consequences of disrupted E3 ubiquitin ligase activity without relying on transient suppression methods.
The RCS (rat chondrosarcoma) cell line originates from a cartilage-derived tumor and serves as a well-established model for chondrocyte biology, extracellular matrix homeostasis, and stress responses. As a transformed cell line, RCS retains features relevant to neoplastic transformation while allowing the study of differentiated chondrocyte functions. Its utility spans osteoarthritis research, tumor microenvironment studies, and cellular responses to mechanical and metabolic stress. The combination with Stub1 knockout creates a powerful system to explore ubiquitin-mediated proteolysis within a chondrosarcoma context.
STUB1 functions as a co-chaperone that collaborates with Hsp70 and Hsp90 molecular chaperones, recruitment of E2 conjugating enzymes such as UbcH5, and the co-chaperone HOP to facilitate ubiquitination of misfolded or aggregation-prone substrates. Its client proteins include tau, huntingtin, mutant p53, and PTEN, linking STUB1 activity to neurodegeneration and cancer. Upstream regulators such as HSF1, MAPKs, and the unfolded protein response modulate STUB1 expression and activation. The CHIP-Hsp70-Hsp90 complex orchestrates substrate targeting to the ubiquitin-proteasome system, ensuring proteostasis under both basal and stress conditions.
In the RCS chondrosarcoma background, deletion of Stub1 disrupts the protein quality control network, sensitizing cells to proteotoxic stress and altering turnover of key regulatory proteins. Because chondrocytes in cartilage are subjected to mechanical load and hypoxia, they rely heavily on chaperone systems and the ubiquitin-proteasome pathway. STUB1 loss in this line may impair clearance of misfolded proteins and affect signaling through client proteins such as PTEN, potentially influencing cell survival, proliferation, and differentiation. This makes the Stub1 Knockout RCS Cell Line a relevant model for studying stress-induced dysfunction in cartilage tumors and degenerative joint diseases.
Typical experimental approaches with this line include western blotting and RT-qPCR to confirm STUB1 ablation, ubiquitination and proteasome activity assays to probe substrate handling, and co-immunoprecipitation to assess interactions with Hsp70/Hsp90 and client proteins like tau or mutant p53. Heat shock assays and immunofluorescence enable visualization of stress responses, while apoptosis and cell viability readouts address functional consequences of impaired proteostasis. Researchers employing this model contribute to understanding proteinopathies, cancer vulnerabilities, and chondrocyte stress responses. For additional information or custom models, please contact Ascent Research.
Case Study
